ADRB2 and Alzheimer disease: Both noradrenaline and isoprenaline promote amyloid β peptide uptake and degradation by murine microglial cells through activation of β2-AR, thus providing a potential link between central noradrenergic neurotransmission and neuroinflammatory mechanisms in Alzheimer's disease (Kong et al., 2010).